CENTRUS ENERGY

Centrus Energy announced a $500 million public offering after the close, consisting of 500,000 common shares, prepaid warrants for roughly 2 million additional shares and warrants for up to nearly 7 million more shares, creating significant potential dilution. The stock fell about 3% in premarket trading after the offering was priced at roughly $199.64 per share. The company cited general working capital, technology development, debt repayment, investments and possible acquisitions as uses of proceeds, without naming specific value-enhancing projects. Analyst sentiment had already soured, and the capital measure heightened short-term execution and valuation concerns, despite a simultaneous report of a multi-year HALEU supply contract with Radiant. » More on de.investing.com

Centrus Energy shares fell 3.9% in after-hours trading after the company announced a guaranteed public offering of Class A common stock as well as pre-funded warrants and warrants. Centrus said it will use the net proceeds for working capital, technology development, debt repayment, capital expenditures and potential acquisitions. At the same time, Centrus announced a multi-year supply contract to provide Radiant with HALEU, strengthening its commercial pipeline, but the market focused on the dilutive impact of the capital raise. Analyst sentiment was already mixed, so uncertainty about the size and terms of the offering weighed on the stock. » More on de.investing.com

Centrus Energy has signed a multi‑year contract to supply HALEU to Radiant; the fuel is intended for the Kaleidos microreactors. Centrus is to begin deliveries before the end of the decade, and Radiant is making advance payments to build domestic enrichment capacity. The fuel will be produced using U.S. technology and a domestic supply chain and is also qualified for national security applications. Centrus points to its ready‑to‑deploy AC100 centrifuge design as the only available U.S. technology for enrichment. » More on de.investing.com